Clinical trials
Phase 1 Pathologic Complete Response trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2012 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| Changchun Intellicrown Pharmaceutical Co. LTD | 1 |
| GlaxoSmithKline | 1 |
| M.D. Anderson Cancer Center | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
| University of Oklahoma | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pathologic Complete Response | 6 |
| Leukemia | 2 |
| Leukemia, Myeloid, Acute | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Hematologic Neoplasms | 1 |
| Histiocytosis, Langerhans-Cell | 1 |
| Hodgkin Disease | 1 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 1 |
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 |
| Lymphoma | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.